Medicare Coverage for GLP-1 Drugs: What You Need to Know

If you're over 65 or have certain disabilities and have seen ads for weight loss drugs like Wegovy or Mounjaro, you're probably wondering: Does Medicare cover GLP-1 drugs for weight loss? The short answer is: it's complicated. Most people assume Medicare would cover these popular medications, but the reality is far more nuanced. This article cuts through the confusion to explain exactly what Medicare covers, what it doesn't, and what steps you need to take to find out if your specific plan will help with weight loss costs. We'll cover the critical exceptions, the role of diabetes diagnosis, and practical steps to navigate your coverage—so you can make informed decisions without wasting time on false hope.

What Medicare Actually Covers for GLP-1 Drugs

First, let's clarify: Medicare Part D (prescription drug coverage) does not cover GLP-1 receptor agonists like semaglutide (Wegovy) or dulaglutide (Mounjaro) solely for weight loss. The Centers for Medicare & Medicaid Services (CMS) only approves coverage when these drugs are used to treat type 2 diabetes or obesity with specific medical conditions. This means Medicare won't pay for weight loss alone—it must be tied to a diagnosed condition. If you have type 2 diabetes, coverage is more likely. If you're seeking weight loss without a qualifying condition, you'll likely pay full price or face significant out-of-pocket costs.

The Diabetes Exception: How It Works

This is the most common path to coverage. If you have a diagnosis of type 2 diabetes, Medicare Part D plans are required to cover GLP-1 drugs used to manage that condition. For example, semaglutide (Ozempic) is FDA-approved for diabetes management and covered under Part D. However, even with diabetes, coverage isn't automatic. Your plan may require prior authorization, meaning your doctor must submit documentation proving the drug is medically necessary for your diabetes care. You might also face step therapy, where you must try cheaper medications first before getting approval for a GLP-1 drug.

Obesity Coverage: The Strict Requirements

Medicare will cover GLP-1 drugs for weight loss only if you meet specific obesity criteria. To qualify, you must have:

A body mass index (BMI) of 30 or higher (classified as obesity)
At least one weight-related health condition, such as high blood pressure, type 2 diabetes, or heart disease

Crucially, your doctor must document these conditions in your medical records. Without this, your plan will deny coverage. Even with these criteria, coverage varies by plan. Some Part D plans include GLP-1s in their formulary (list of covered drugs) for obesity, while others don't. There's no federal mandate requiring all plans to cover weight loss specifically—even with obesity and comorbidities.

Medicare Advantage Plans (Part C): A Different Story

If you have a Medicare Advantage plan (Part C), coverage can be even more unpredictable. These plans are run by private companies and must cover all Part A and Part B services, but they handle drug coverage differently. Some Advantage plans include GLP-1 drugs for weight loss in their formulary, while others don't. The key difference: Advantage plans often have lower out-of-pocket costs than standard Part D, but you must check if your specific plan covers the drug. Always verify with your plan's formulary or call customer service—don't assume.

How to Check If Your Plan Covers GLP-1 Drugs

Don't guess—ask. Here's how to find out for sure:

Review your plan's formulary: Access your plan's drug list online or request a copy from your plan provider. Search for "GLP-1," "semaglutide," or "Wegovy."
Call your plan's customer service: Ask: "Does this plan cover semaglutide (Wegovy) for weight loss with a BMI of 30+ and hypertension?"
Ask your doctor to submit prior authorization: If your doctor agrees the drug is medically necessary, they can request approval from your plan.

Be prepared for potential hurdles: Your plan might require a trial of lower-cost weight loss medications first (step therapy), or it might cover the drug only for diabetes management, not weight loss specifically. In some cases, you'll pay 100% of the cost until the plan approves coverage.

What You'll Likely Pay Out of Pocket

Even if your plan covers GLP-1 drugs, out-of-pocket costs can be high. Without coverage, a month's supply of Wegovy costs about $1,300. With Part D, you might pay:

35% of the drug cost after meeting your deductible (if you're in the coverage gap)
15-30% of the cost during the initial coverage phase

For example, if your deductible is $500 and the drug costs $1,300/month, you'd pay $500 before coverage kicks in. Then, you'd pay 35% of $1,300 ($455) each month until you hit the out-of-pocket maximum. If you don't meet the obesity criteria, you'll likely pay the full $1,300 monthly cost. Always get a cost estimate from your pharmacy before filling the prescription.

Why Medicare Doesn't Cover Weight Loss Alone

Medicare's coverage rules are based on "medical necessity." The agency views weight loss as a lifestyle goal, not a medical condition requiring drug intervention. This is why coverage is tied to diabetes or obesity with comorbidities. CMS prioritizes conditions with proven health risks (like diabetes complications) over cosmetic or non-essential weight loss. This policy has been criticized by patient advocates, but it's unlikely to change soon.

Alternatives If Medicare Doesn't Cover Your GLP-1 Drug

If your plan denies coverage, consider these options:

Switch to a Part D plan with better coverage: During Medicare's annual enrollment period (Oct 15–Dec 7), compare plans that include GLP-1s in their formulary.
Ask about manufacturer assistance programs: Companies like Novo Nordisk offer patient assistance programs for eligible individuals (income-based), but these aren't insurance substitutes.
Explore lower-cost weight management options: Medicare Part B covers obesity counseling (up to 20 sessions yearly) for people with a BMI of 30+ and comorbidities. This includes dietitian visits and behavioral therapy—no prescription needed.

Common Mistakes to Avoid

Many people make these errors when seeking GLP-1 coverage:

Assuming all plans cover it: Coverage varies widely. One plan might cover Wegovy for obesity, another might not.
Not verifying your doctor's documentation: Without clear records of your BMI and comorbidities, prior authorization will fail.
Ignoring the diabetes exception: If you have diabetes, emphasize this in your doctor's request for coverage.
Waiting until you run out of medication: Start the prior authorization process before your current supply ends to avoid gaps in care.

When to Consider Alternatives to GLP-1 Drugs

If coverage remains elusive, focus on evidence-based weight management strategies covered by Medicare:

Medicare-covered weight loss programs: The Diabetes Prevention Program (DPP) is covered for people with prediabetes (no cost-sharing).
Prescription weight loss medications with better coverage: Some non-GLP-1 drugs like phentermine-topiramate (Qsymia) may be covered for obesity, but they're less common.
Lifestyle interventions: Medicare Part B covers 100% of obesity counseling with a physician, including meal planning and exercise guidance.

Key Takeaways for Medicare Beneficiaries

Medicare doesn't cover GLP-1 drugs for weight loss alone. Coverage requires either a type 2 diabetes diagnosis or obesity with comorbidities (BMI ≥30 + conditions like hypertension). Always verify coverage with your specific plan—don't assume. If denied, explore Medicare-covered alternatives like obesity counseling or switch plans during open enrollment. Most importantly: work with your doctor to document your medical needs for prior authorization. This process takes effort, but it's the only path to getting coverage for these expensive medications.